Forecast: Basic Pharmaceutical Products Turnover in Italy

The turnover of basic pharmaceutical products in Italy gradually increased from 4.55 billion Euros in 2013 to 5.75 billion Euros in 2023. The sector experienced fluctuations, with a noticeable decline in 2014 and significant growth in 2015 and 2019. The year-on-year variations highlighted both positive and negative changes, such as an 8.63% decrease in 2014 and an 8.71% increase in 2019. The Compound Annual Growth Rate (CAGR) depicted an average yearly growth with notable peaks and declines over the period. By 2023, the sector had a CAGR of 3.89% over the last five years.

Future trends to watch for include:

- The projected steady growth in turnover from 2024 to 2028, with an estimated CAGR of 1.89% and an overall growth rate of 9.81% by 2028.

- Advancements in pharmaceutical technology and research which can significantly impact production efficiencies and market dynamics.

- Policy changes and economic shifts in Italy and Europe affecting the pharmaceutical regulations and market performance.